
CLAUSSEN, H., BUNING, C., RAEREY, M., LENGAUER, T. FlexE: efficient molecular docking
considering protein structure variations. J. Mol. Biol., vol. 308, p. 377-95, 2001.
D’ALFONSO, G.; TRAMONTANO, A.; LAHM, A. Structural Conservation in Single-Domain
Proteins: Implications for Homology Modeling. J. Struct. Bio, vol. 134, p. 246-256, 2001.
EKINS, S., DE GROOT, M. J., JONES, J. P. Pharmacophore and three-dimensional quantitative
structure activity relationship methods for modeling cytochrome P450 active sites. Drug Me-
tab. Dispos, vol. 29, p. 936-44, 2001.
FIGUEIREDO, J. E. F.; CASCARDO, J. M.; CAROLINO, S. M. B.; FONTES, E. P. B. Waterstress
regulation and molecular analysis of the soybean BiP gene family. Brazilian Journal of Plant
Physiology, Piracicaba, vol. 9, nº 2, p. 103-110, 1997.
FIGUEIREDO, J. E. F. BiP-storage protein interactions and isolation of BiP cDNA and BiP ge-
nomic clones from soybean [Glycine max (L.) Merrill]. Genetics and Molecular Biology, Ri-
beirão Preto, vol. 21, p. 579-580, 1998a.
FOSTER, M. J. Molecular modelling in structural biology. Mícron, vol. 33, p. 365-384, 2002.
HENRIQUES, J. A. P. Genética toxicológica. 1ª ed. Porto Alegre: Alcance, 2003. Cap. Metabo-
lismo de Xenobióticos: Citocromo P-450, p. 225-247.
HUGHES, J. E. Genomic technologies in drug discovery and development. Drug discovery
today, vol. 4 (1), p. 6, 1999.
KITCHEN, D. B., DECORNEZ, H., FURR, J., BAJORATH, J., Docking and Scoring In Vir-
tual Screening for Drug Discovery: Methods and Applications. Drug discovery, vol. 3,
p. 935-949, 2004.
LUNDSTROM, K. Structural genomics: the ultimate approach for rational drug design. Mol
Biotechnol, vol. 34 (2), p. 205-12, 2006.
NORWELL, J. C.; MACHALEK, A. Z. Structural genomics programs at the US National Institute
of General Medical Sciences. Nat. Struct. Biol, vol. 7, p. 931, 2000.
ORTIZ, A. R.; KOLINSKI, A.; SKOLNICK, J. Fold assembly of small proteins using Monte Carlo
simulations driven by restraints derived from multiple sequence alignments. J. Mol. Biol, vol.
277, p. 419-448, 1998.
PANG, T. Impact of pharmacogenomics on neglected diseases of the developing world. Am J
Pharmacogenomics, vol. 3 (6), p. 393-8, 2003.
PHILIPS, K. A., VEENSTRA, D. L., OREN, E., LEE, J. K. and SADEE, W. Potential role of phar-
macogenomics in reducing adverse drug reactions: a systematic review. JAMA, vol. 286, p.
2270-2279, 2001.
SANCHEZ, R., SALI, A. Comparative protein structure modeling. Introduction and practical
examples with modeller. Methods Mol. Biol., vol. 143, p. 97-129, 2000.
SILVEIRA, N. J. F. Bioinformática Estrutural Aplicada ao Estudo de Proteínas Alvo do Genoma
do Mycobacterium tuberculosis. São José do Rio Preto, 2005. 117 p. Tese (Doutorado em
Biofísica Molecular) – Universidade Estadual Paulista.
STERNBERG, M. J., ALOY, P., GABB, H .A., JACKSON, R. M., MOONT, G. et alii. A computa-
tional system for modelling flexible protein-protein and protein-DNA docking. Proc. Int. Conf.
Intell. Syst. Mol. Biol.
, vol. 6, p. 183-92, 1998.
SUNYAEV, S., LATHE, W., BORK, P. Integration of genome data and protein structures: pre-
diction of protein folds, protein interactions and “molecular phenotypes” of single nucleotide
polymorphisms. Curr. Opin. Struct. Biol., vol. 11, p. 125-30, 2001.
TAKEDA-SHITAKA, M., TAKAYA, D., CHIBA, C., TANAKA, H., UMEYAMA, H. Protein structure
prediction in structure based drug design. Curr Med Chem, vol. 11 (5), p. 551-8, 2004.
TERWILLIGER, T.C. Structural genomics in North America. Nat. Struct. Biol., vol. 7, p.
935-939, 2000.
TROTTA, R.; DONATI, M. B.; IACOVIELLO, L. Trends in pharmacogenomics of drug acting on
hypertension. Pharmacological research, vol. 49 (4), p. 351-356, 2004.
WALKER, M. R.; RAPLEY, R. Guia de rotas na tecnologia do gene. Atheneu, São P
aulo, Brasil,
334 p., 1999.
WATSON, J. D., SANDERSON, S., EZERSKY, A., SAVCHENKO, A., EDWARDS, A., ORENGO,
C., JOACHIMIAK, A., LASKOWSKI, R. A., THORNTON, J. M. Towards Fully Automated Struc-
ture-based Function Prediction in Structural Genomics: A Case Study, J Mol Bio, vol. 367 (5),
p. 1511-22, 2007.
XIANG, Z. Advances in homology protein structure modeling. Curr Protein Pept Sci, vol.
7 (3), p. 217-27, 2006.
YAGIL, Y.; YAGIL, C. Insights into pharmacogenomics and its impact upon immunosuppressive
therapy. Transplant immunology, vol. 9 (2-4), p. 203-209, 2002.